Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Angewandte Chemie (International Ed. in English)|August 31, 2017
Lysine-Targeting Covalent InhibitorsJonathan Pettinger, Keith Jones, Matthew D CheesemanChemical Communications (Cambridge, England)|April 26, 2017
Targeting secondary protein complexes in drug discovery: studying the druggability and chemical biology of the HSP70/BAG1 complexLindsay E Evans, Keith Jones, Matthew D CheesemanOrganic Letters|June 28, 2012
N-N bond-forming cyclization for the one-pot synthesis of N-aryl[3,4-d]pyrazolopyrimidinesLindsay E Evans, Matthew D Cheeseman, Keith JonesJournal of Medicinal Chemistry|November 15, 2019
Kinetic Optimization of Lysine-Targeting Covalent Inhibitors of HSP72Jonathan Pettinger, Michael Carter, Keith Jones, et al.Plos One|October 13, 2015
Investigating Apoptozole as a Chemical Probe for HSP70 InhibitionLindsay E Evans, Matthew D Cheeseman, Norhakim Yahya, et al.Organic & Biomolecular Chemistry|October 22, 2008
Synthesis of (+)-DGDP and (-)-7-epialexineTimothy J Donohoe, Matthew D Cheeseman, Timothy J C O'Riordan, et al.Organic Letters|July 19, 2008
Flexible strategy for the synthesis of pyrrolizidine alkaloidsTimothy J Donohoe, Rhian E Thomas, Matthew D Cheeseman, et al.Angewandte Chemie (International Ed. in English)|February 23, 2017
An Irreversible Inhibitor of HSP72 that Unexpectedly Targets Lysine-56Jonathan Pettinger, Yann-Vaï Le Bihan, Marcella Widya, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2014
Targeting the PPM1D phenotype; 2,4-bisarylthiazoles cause highly selective apoptosis in PPM1D amplified cell-linesMatthew D Cheeseman, Amir Faisal, Sydonia Rayter, et al.Journal of Medicinal Chemistry|April 28, 2016
Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70Matthew D Cheeseman, Isaac M Westwood, Olivier Barbeau, et al.Pageof 2